Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:487  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB
Somenath Roy Chowdhury,Ashish Kumar,Joseane Lima Prado Godinho,Sara Teixeira De Macedo Silva,Aline Araujo Zuma,Sourav Saha,Neha Kumari,Juliany Cola Fernandes Rodrigues,Shyam Sundar,Jean-Claude Dujardin,Syamal Roy,Wanderley De Souza,Sibabrata Mukhopadhyay,Hemanta K. Majumder
Biochemical Pharmacology.2017;138()19
[DOI]
2Optimal combinations of control strategies and cost-effective analysis for visceral leishmaniasis disease transmission
Santanu Biswas,Abhishek Subramanian,Ibrahim M. ELMojtaba,Joydev Chattopadhyay,Ram Rup Sarkar,Henk D. F. H. Schallig
PLOS ONE.2017;12(2)e0172465
[DOI]
3Isatis tinctoria mediated synthesis of amphotericin B-bound silver nanoparticles with enhanced photoinduced antileishmanial activity: A novel green approach
Aftab Ahmad,Yun Wei,Fatima Syed,Shafiullah Khan,Gul Majid Khan,Kamran Tahir,Arif Ullah Khan,Muslim Raza,Faheem Ullah Khan,Qiping Yuan
Journal of Photochemistry and Photobiology B: Biology.2016;161(2)17
[DOI]
4Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids
Marcel Kaiser,Louis Maes,Leela Pavan Tadoori,Thomas Spangenberg,Jean-Robert Ioset
Journal of Biomolecular Screening.2015;20(5)634
[DOI]
5An Overview of Drug Resistance in Protozoal Diseases
Jean-Robert Capela,Jean-Robert Moreira,Jean-Robert Lopes
International Journal of Molecular Sciences.2019;20(22)5748
[DOI]
6Antileishmanial effects of the alkaloid-rich fraction of Quassia amara L.
S. Gabriel Renata,Claudia F. Amaral Ana,Corte-Real Suzana,C. Lopes Rosana,S. Alviano Celuta,B. Vermelho Alane,S. Alviano Daniela,A. Rodrigues Igor
Journal of Medicinal Plants Research.2016;10(42)775
[DOI]
7A review of current treatments strategies based on paromomycin for leishmaniasis
A.P.S. Matos,A.L. Viçosa,M.I. Ré,E. Ricci-Júnior,C. Holandino
Journal of Drug Delivery Science and Technology.2020;57(42)101664
[DOI]
8In Vitro Anti-Leishmanial Effect of Metallic Meso-Substituted Porphyrin Derivatives against Leishmania braziliensis and Leishmania panamensis Promastigotes Properties
Fabian Espitia-Almeida,Carlos Díaz-Uribe,William Vallejo,Doris Gómez-Camargo,Arnold R. Romero Bohórquez
Molecules.2020;25(8)1887
[DOI]
9Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform
Jacob T. Bush,Monique Wasunna,Fabiana Alves,Jorge Alvar,Piero L. Olliaro,Michael Otieno,Carol Hopkins Sibley,Nathalie Strub Wourgaft,Philippe J. Guerin,Waleed Saleh Al-Salem
PLOS Neglected Tropical Diseases.2017;11(9)e0005781
[DOI]
10Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform
Nasib Singh,Anuradha Dube
PLOS Neglected Tropical Diseases.2015;11(9)1
[DOI]
11Cytotoxic Activity ofHolothuria leucospilotaExtract againstLeishmania infantum In Vitro
Shahram Khademvatan,Alborz Eskandari,Jasem Saki,Masoud Foroutan-Rad
Advances in Pharmacological Sciences.2016;2016(9)1
[DOI]
12Cytotoxic Activity ofHolothuria leucospilotaExtract againstLeishmania infantum In Vitro
Philippe M. Loiseau,Gillian Barratt
Advances in Pharmacological Sciences.2013;2016(9)321
[DOI]
13Molecular modeling and simulation study of homoserine kinase as an effective leishmanial drug target
Rohan J. Meshram,Akshay Shirsath,Snehal Aouti,Kamini Bagul,Rajesh N. Gacche
Journal of Molecular Modeling.2020;26(8)321
[DOI]
14Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered In Vivo Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis
Diana Caridha,Sandi Parriot,Thomas H. Hudson,Thierry Lang,Franklyn Ngundam,Susan Leed,Jenell Sena,Michael Harris,Michael O'Neil,Richard Sciotti,Lisa Read,Herve Lecoeur,Mark Hickman,Max Grogl
Antimicrobial Agents and Chemotherapy.2017;61(4)321
[DOI]
15Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasis
Satish Chandra Pandey,Awanish Kumar,Mukesh Samant
Parasite Immunology.2020;42(9)321
[DOI]
16In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates
Sarah Hendrickx,Lieselotte Van Bockstal,Guy Caljon,Louis Maes,Kiyoshi Kita
PLOS Neglected Tropical Diseases.2019;13(12)e0007885
[DOI]
17Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
Arun Kumar Haldar,Pradip Sen,Syamal Roy
Molecular Biology International.2011;2011(12)1
[DOI]
18Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
Vandana Soni,Silki Chandel,Vikas Pandey,Saket Asati,Priyanka Jain,Aviral Jain,Rakesh K. Tekade
Molecular Biology International.2019;2011(12)263
[DOI]
19Structure and Antiparasitic Activity Relationship of Alkylphosphocholine Analogues against Leishmania donovani
Humera Ahmed,Katharine C. Carter,Roderick A.M. Williams
Microorganisms.2020;8(8)1117
[DOI]
20Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis
M. J. Corral,D. R. Serrano,I. Moreno,J. J. Torrado,M. Dominguez,J. M. Alunda
Journal of Antimicrobial Chemotherapy.2014;69(12)3268
[DOI]
215-Substituted 3-chlorokenpaullone derivatives are potent inhibitors of Trypanosoma brucei bloodstream forms
Oliver C.F. Orban,Ricarda S. Korn,Diego Benítez,Andrea Medeiros,Lutz Preu,Nadège Loaëc,Laurent Meijer,Oliver Koch,Marcelo A. Comini,Conrad Kunick
Bioorganic & Medicinal Chemistry.2016;24(16)3790
[DOI]
22Sand Fly Studies Predict Transmission Potential of Drug-resistant Leishmania
Lieselotte Van Bockstal,Sarah Hendrickx,Louis Maes,Guy Caljon
Trends in Parasitology.2020;36(9)785
[DOI]
23Modeling and simulation study to identify threonine synthase as possible drug target in Leishmania major
Rohan J. Meshram,Kamini T. Bagul,Snehal U. Aouti,Akshay M. Shirsath,Harleen Duggal,Rajesh N. Gacche
Molecular Diversity.2020;36(9)785
[DOI]
24In VitroSensitivity of PairedLeishmania(Viannia)braziliensisSamples Isolated before Meglumine Antimoniate Treatment and after Treatment Failure or Reactivation of Cutaneous Leishmaniasis
Cibele Baptista,Luciana de Freitas Campos Miranda,Maria de Fátima Madeira,Leonor Laura Pinto Leon,Fátima Conceição-Silva,Armando de Oliveira Schubach
Disease Markers.2015;2015(9)1
[DOI]
25Leishmaniasis: treatment, drug resistance and emerging therapies
Shyam Sundar,Jaya Chakravarty,Lalit P Meena
Expert Opinion on Orphan Drugs.2019;7(1)1
[DOI]
26Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana
Sanjay Varikuti,Steve Oghumu,Noushin Saljoughian,Marissa S. Pioso,Bren E Sedmak,Ali Khamesipour,Abhay R. Satoskar
Acta Tropica.2017;173(1)102
[DOI]
27Liposomal formulations in the pharmacological treatment of leishmaniasis: a review
Vanessa Ortega,Selma Giorgio,Eneida de Paula
Journal of Liposome Research.2017;27(3)234
[DOI]
28Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial
Mohammad Mahdi Parvizi,Farhad Handjani,Mahmoodreza Moein,Gholamreza Hatam,Majid Nimrouzi,Jafar Hassanzadeh,Nasrin Hamidizadeh,Hamid Reza Khorrami,Mohammad Mehdi Zarshenas,Waleed Saleh Al-Salem
PLOS Neglected Tropical Diseases.2017;11(10)e0005957
[DOI]
29Deficiency of Leishmania Phosphoglycans Influences the Magnitude but Does Not Affect the Quality of Secondary (Memory) Anti-Leishmania Immunity
Dong Liu,Ifeoma Okwor,Zhirong Mou,Stephen M. Beverley,Jude E. Uzonna,Simona Stager
PLoS ONE.2013;8(6)e66058
[DOI]
30Deficiency of Leishmania Phosphoglycans Influences the Magnitude but Does Not Affect the Quality of Secondary (Memory) Anti-Leishmania Immunity
Louis Maes,Raquel Andreia Inocencio da Luz,Paul Cos,Vanessa Yardley
PLoS ONE.2013;8(6)301
[DOI]
31Nucleic acid sensing activates the innate cytosolic surveillance pathway and promotes parasite survival in visceral leishmaniasis
Sushmita Das,Ashish Kumar,Abhishek Mandal,Kumar Abhishek,Sudha Verma,Ajay Kumar,Pradeep Das
Scientific Reports.2019;9(1)301
[DOI]
32Need for sustainable approaches in antileishmanial drug discovery
Sarah Hendrickx,G. Caljon,L. Maes
Parasitology Research.2019;118(10)2743
[DOI]
33Formulation and characterisation of a self-nanoemulsifying drug delivery system of amphotericin B for the treatment of leishmaniasis
Momin Khan,Akhtar Nadhman,Walayat Shah,Imran Khan,Masoom Yasinzai
IET Nanobiotechnology.2019;13(5)477
[DOI]
34Study of Ethinyl Estradiol Activity Against Promastigotes, Axenic and Macrophage-Dwelling Amastigotes of Leishmania infantum by Using Atomic Force Microscopy and Methyl Thiazolyl Tetrazolium Methods
Farnoush Shadnoush,Reza Arjmand,Fakher Rahim,Jasem Saki
Jundishapur Journal of Microbiology.2019;12(8)477
[DOI]
35Study of Ethinyl Estradiol Activity Against Promastigotes, Axenic and Macrophage-Dwelling Amastigotes of Leishmania infantum by Using Atomic Force Microscopy and Methyl Thiazolyl Tetrazolium Methods
Joachim Kloehn,Eleanor C. Saunders,Malcolm J. McConville
Jundishapur Journal of Microbiology.2016;12(8)83
[DOI]
36Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs
Chiara Borsari,Rosaria Luciani,Cecilia Pozzi,Ina Poehner,Stefan Henrich,Matteo Trande,Anabela Cordeiro-da-Silva,Nuno Santarem,Catarina Baptista,Annalisa Tait,Flavio Di Pisa,Lucia Dello Iacono,Giacomo Landi,Sheraz Gul,Markus Wolf,Maria Kuzikov,Bernhard Ellinger,Jeanette Reinshagen,Gesa Witt,Philip Gribbon,Manfred Kohler,Oliver Keminer,Birte Behrens,Luca Costantino,Paloma Tejera Nevado,Eugenia Bifeld,Julia Eick,Joachim Clos,Juan Torrado,María D. Jiménez-Antón,María J. Corral,José M Alunda,Federica Pellati,Rebecca C. Wade,Stefania Ferrari,Stefano Mangani,Maria Paola Costi
Journal of Medicinal Chemistry.2016;59(16)7598
[DOI]
37Chemoprevention of Leishmaniasis: In - vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani
Indira Singh Chauhan,G. Subba Rao,Jai Shankar,Lalit Kumar Singh Chauhan,Govind J. Kapadia,Neeloo Singh
Parasitology International.2018;67(5)627
[DOI]
38Chemoprevention of Leishmaniasis: In - vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani
Nasib Singh,Anuradha Dube
Parasitology International.2016;67(5)2325
[DOI]
39Chemoprevention of Leishmaniasis: In - vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani
Chiara Borsari,Antonio Quotadamo,Stefania Ferrari,Alberto Venturelli,Anabela Cordeiro-da-Silva,Nuno Santarem,Maria Paola Costi
Parasitology International.2018;51(5)39
[DOI]
40Biochemical and structural characterization of tyrosine aminotransferase suggests broad substrate specificity and a two-state folding mechanism in Leishmania donovani
Santanu Sasidharan,Prakash Saudagar
FEBS Open Bio.2019;9(10)1769
[DOI]
41The severity of cutaneous leishmaniasis before and after the earthquake in Bam, southeastern Iran
Iraj Sharifi,Mohammad Reza Aflatoonian,Behnaz Aflatoonian,Alireza Kermanizadeh
Journal of Parasitic Diseases.2015;39(4)741
[DOI]
42Anti-leishmanial and cytotoxic activities of amino acid-triazole hybrids: Synthesis, biological evaluation, molecular docking and in silico physico-chemical properties
Mir Mohammad Masood,Phool Hasan,Shams Tabrez,Md. Bilal Ahmad,Umesh Yadava,Constantin G. Daniliuc,Yogesh A. Sonawane,Amir Azam,Abdur Rub,Mohammad Abid
Bioorganic & Medicinal Chemistry Letters.2017;27(9)1886
[DOI]
43Ultrastructural Analysis ofLeishmania infantum chagasiPromastigotes Forms TreatedIn Vitrowith Usnic Acid
João S. B. da Luz,Erwelly B. de Oliveira,Monica C. B. Martins,Nicácio H. da Silva,Luiz C. Alves,Fábio A. B. dos Santos,Luiz L. S. da Silva,Eliete C. Silva,Paloma L. de Medeiros
The Scientific World Journal.2015;2015(9)1
[DOI]
44Antiprotozoal glutathione derivatives with flagellar membrane binding activity against T. brucei rhodesiense
Sylvie Daunes,Vanessa Yardley,Simon L. Croft,Claudius D'Silva
Bioorganic & Medicinal Chemistry.2017;25(4)1329
[DOI]
45Antiprotozoal glutathione derivatives with flagellar membrane binding activity against T. brucei rhodesiense
Nozomu Nihashi,Daniel Ken Inaoka,Chiaki Tsuge,Emmanuel Oluwadare Balogun,Yasutaka Osada,Yasuyuki Goto,Yoshitsugu Matsumoto,Takeshi Nara,Tatsushi Mogi,Shigeharu Harada,Kita Kiyoshi
Bioorganic & Medicinal Chemistry.2016;25(4)101
[DOI]
46Leishmania donovani-specific 25- and 28-kDa urinary proteins activate macrophage effector functions, lymphocyte proliferation and Th1 cytokines production
Vinod Kumar,Jalaj K. Gour,Nisha Singh,Surabhi Bajpai,Rakesh K. Singh
Parasitology Research.2013;112(4)1427
[DOI]
47Flow cytometry technique for analysingLeishmaniapromastigote phagocytosis by human polymorphonuclear leucocytes and monocytes
K. REBBESTAD,S. HERREDSVELA,S. SORNES,G. E. EIDE,K. E. MÜLLER,E. SPRIET,H. SJURSEN,A. NAESS
Parasite Immunology.2012;34(11)528
[DOI]
48Synthesis and anti-leishmanial evaluation of 1-phenyl-2,3,4,9-tetrahydro-1 H -ß-carboline derivatives against Leishmania infantum
Penta Ashok,Subhash Chander,Ana Tejería,Laura García-Calvo,Rafael Balaña-Fouce,Sankaranarayanan Murugesan
European Journal of Medicinal Chemistry.2016;123(11)814
[DOI]
49Chiral Cyclobutane-Containing Cell-Penetrating Peptides as Selective Vectors for Anti-Leishmania Drug Delivery Systems
Ona Illa,José-Antonio Olivares,Nerea Gaztelumendi,Laura Martínez-Castro,Jimena Ospina,María-Ángeles Abengozar,Giuseppe Sciortino,Jean-Didier Maréchal,Carme Nogués,Míriam Royo,Luis Rivas,Rosa M. Ortuño
International Journal of Molecular Sciences.2020;21(20)7502
[DOI]
50Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
Advait S. Nagle,Shilpi Khare,Arun Babu Kumar,Frantisek Supek,Andriy Buchynskyy,Casey J. N. Mathison,Naveen Kumar Chennamaneni,Nagendar Pendem,Frederick S. Buckner,Michael H. Gelb,Valentina Molteni
Chemical Reviews.2014;114(22)11305
[DOI]
51Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar
P. Malaviya,E. Hasker,R. P. Singh,J. P. Van Geertruyden,M. Boelaert,S. Sundar
Tropical Medicine & International Health.2013;18(2)188
[DOI]
52Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar
Begoña Monge-Maillo,Rogelio López-Vélez
Tropical Medicine & International Health.2018;18(2)169
[DOI]
53SWATH-MS based quantitative proteomics analysis to evaluate the antileishmanial effect of Commiphora wightii- Guggul and Amphotericin B on a clinical isolate of Leishmania donovani
Chinmayee Bar Routaray,Renuka Bhor,Shakuntala Bai,Nitin Suryakant Kadam,Surabhi Jagtap,Pooja Jignesh Doshi,Shyam Sundar,Sangeeta Sawant,Mahesh J. Kulkarni,Kalpana Pai
Journal of Proteomics.2020;223(2)103800
[DOI]
54Possibilities and challenges for developing a successful vaccine for leishmaniasis
Saumya Srivastava,Prem Shankar,Jyotsna Mishra,Sarman Singh
Parasites & Vectors.2016;9(1)103800
[DOI]
55High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
Ermias Diro,Lutgarde Lynen,Rezika Mohammed,Marleen Boelaert,Asrat Hailu,Johan van Griensven,Hechmi Louzir
PLoS Neglected Tropical Diseases.2014;8(5)e2875
[DOI]
56Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
Sarah Hendrickx,Magali Van den Kerkhof,Dorien Mabille,Paul Cos,Peter Delputte,Louis Maes,Guy Caljon,Charles L. Jaffe
PLOS Neglected Tropical Diseases.2017;11(5)e0005620
[DOI]
57Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
Mallikarjuna Rao Gedda,Om Prakash Singh,Onkar Nath Srivastava,Shyam Sundar
PLOS Neglected Tropical Diseases.2019;11(5)195
[DOI]
58Antileishmanial activities of caffeic acid phenethyl ester loaded PLGA nanoparticles against Leishmania infantum promastigotes and amastigotes in vitro
Emrah Sefik Abamor
Asian Pacific Journal of Tropical Medicine.2017;10(1)25
[DOI]
59Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors
Larissa de Mattos Oliveira,Janay Stefany Carneiro Araújo,David Bacelar Costa Junior,Isis Bugia Santana,Angelo Amâncio Duarte,Franco Henrique Andrade Leite,Raquel Guimarães Benevides,Manoelito Coelho dos Santos Junior
Journal of Molecular Modeling.2018;24(11)25
[DOI]
60Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors
Jette Pretzel,Franziska Mohring,Stefan Rahlfs,Katja Becker
Journal of Molecular Modeling.2013;135(11)157
[DOI]
61Imipramine Exploits Histone Deacetylase 11 To Increase the IL-12/IL-10 Ratio in Macrophages Infected with Antimony-ResistantLeishmania donovaniand Clears Organ Parasites in Experimental Infection
Sandip Mukherjee,Budhaditya Mukherjee,Rupkatha Mukhopadhyay,Kshudiram Naskar,Shyam Sundar,Jean-Claude Dujardin,Syamal Roy
The Journal of Immunology.2014;193(8)4083
[DOI]
62ParaPep: a web resource for experimentally validated antiparasitic peptide sequences and their structures
D. Mehta,P. Anand,V. Kumar,A. Joshi,D. Mathur,S. Singh,A. Tuknait,K. Chaudhary,S. K. Gautam,A. Gautam,G. C. Varshney,G. P. S. Raghava
Database.2014;2014(0)bau051
[DOI]
63Leishmania infantum LeIF and its recombinant polypeptides induce the maturation of dendritic cells in vitro: An insight for dendritic cells based vaccine
Mourad Barhoumi,Olga S. Koutsoni,Eleni Dotsika,Ikram Guizani
Immunology Letters.2019;210(0)20
[DOI]
64Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain
Sarah Hendrickx,Annelies Leemans,Annelies Mondelaers,Suman Rijal,Basudha Khanal,Jean-Claude Dujardin,Peter Delputte,Paul Cos,Louis Maes,Henk D. F. H. Schallig
PLOS ONE.2015;10(10)e0140139
[DOI]
65Clinical aspects of visceral leishmaniasis in HIV infection
Joseph N. Jarvis,Diana N. Lockwood
Current Opinion in Infectious Diseases.2013;26(1)1
[DOI]
66Clinical aspects of visceral leishmaniasis in HIV infection
Neeraj Tiwari,Arun Kumar,Ashish K. Singh,Surabhi Bajpai,Anand K. Agrahari,Dhiraj Kishore,Vinod K. Tiwari,Rakesh K. Singh
Current Opinion in Infectious Diseases.2019;26(1)293
[DOI]
67Efficient infection of hamster with Leishmania donovani by retro-orbital inoculation
M. D. Jiménez-Antón,M. Grau,M. J. Corral,A. I. Olías-Molero,J.M. Alunda
Virulence.2019;10(1)711
[DOI]
68Mapping N- and C-terminals of Leishmania donovani tyrosine aminotransferase by gene truncation strategy: a functional study using in vitro and in silico approaches
Santanu Sasidharan,Prakash Saudagar
Scientific Reports.2020;10(1)711
[DOI]
69Antileishmanial Activity of Warifteine: A Bisbenzylisoquinoline Alkaloid Isolated fromCissampelos sympodialisEichl. (Menispermaceae)
Eliete Cavalcanti da Silva,Cynthia Dias Rayol,Paloma Lys Medeiros,Regina Célia Bressan Queiroz Figueiredo,Márcia Regina Piuvezan,José Maria Brabosa-Filho,Alexsandro Fernandes Marinho,Teresinha Gonçalves Silva,Gardenia Carmen Gadelha Militão,Ana Paula Pimentel Cassilhas,Paulo Paes de Andrade
The Scientific World Journal.2012;2012(1)1
[DOI]
70Focus on PAINS: false friends in the quest for selective anti-protozoal lead structures from Nature?
J. Glaser,U. Holzgrabe
MedChemComm.2016;7(2)214
[DOI]
71<i>Seco</i>-limonoid 11<i>a</i>,19<i>ß</i>-dihydroxy-7-acetoxy-7- deoxoichangin promotes the resolution of <i>Leishmania panamensis</i> infection
Diana Granados-Falla,Carlos Coy-Barrera,Luis Cuca,Gabriela Delgado
Advances in Bioscience and Biotechnology.2013;04(02)304
[DOI]
72<i>Seco</i>-limonoid 11<i>a</i>,19<i>ß</i>-dihydroxy-7-acetoxy-7- deoxoichangin promotes the resolution of <i>Leishmania panamensis</i> infection
Bruce A. Fowler,Emily F. Madden,Selene Chou
Advances in Bioscience and Biotechnology.2012;04(02)475
[DOI]
73Discovery of novel anti-leishmanial agents targeting LdLip3 lipase
Saravanan Parameswaran,Prakash Saudagar,Vikash Kumar Dubey,Sanjukta Patra
Journal of Molecular Graphics and Modelling.2014;49(02)68
[DOI]
74In vitro activity of Erythrophleum ivorense extract against the promastigote stage of cutaneous Leishmania parasite, a member of Leishmania (Mundinia) enriettii complex isolates from Ghana
Alberta Serwah Anning,Godwin Kwakye-Nuako,Elvis Ofori Ameyaw,Mba-Tihssommah Mosore,Kwame Kumi Asare
Access Microbiology.2019;1(7)68
[DOI]
75In vitro activity of Erythrophleum ivorense extract against the promastigote stage of cutaneous Leishmania parasite, a member of Leishmania (Mundinia) enriettii complex isolates from Ghana
Niteshkumar U. Sahu,Chetan P. Shah,Janvhi S. Machhar,Prashant S. Kharkar
Access Microbiology.2019;1(7)399
[DOI]
76VOSalophen: a vanadium complex with a stilbene derivative—induction of apoptosis, autophagy, and efficiency in experimental cutaneous leishmaniasis
Patrícia de A. Machado,Jessica O. F. Morais,Gustavo S. G. Carvalho,Wallace P. Lima,Gilson C. Macedo,Elizandra A. Britta,Celso V. Nakamura,Adilson D. da Silva,Alexandre Cuin,Elaine S. Coimbra
JBIC Journal of Biological Inorganic Chemistry.2017;22(6)929
[DOI]
77Knockdown of LdMC1 and Hsp70 by antisense oligonucleotides causes cell-cycle defects and programmed cell death in Leishmania donovani
Puneet Raina,Sukhbir Kaur
Molecular and Cellular Biochemistry.2012;359(1-2)135
[DOI]
78Immunomodulation of dual specificity phosphatase 4 during visceral leishmaniasis
Shabina Parveen,Atish Roy Chowdhury,Junaid Jibran Jawed,Suchandra Bhattacharyya Majumdar,Bhaskar Saha,Subrata Majumdar
Microbes and Infection.2018;20(2)111
[DOI]
79In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes
Shahram Khademvatan,Neda Adibpour,Alborz Eskandari,Saeed Rezaee,Mahmoud Hashemitabar,Fakher Rahim
Experimental Parasitology.2013;135(2)208
[DOI]
80Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges
Kiran Saleem,Zainab Khursheed,Christophe Hano,Iram Anjum,Sumaira Anjum
Nanomaterials.2019;9(12)1749
[DOI]
81The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo
Sourav Saha,Tulika Mukherjee,Sayan Chowdhury,Amartya Mishra,Somenath Roy Chowdhury,Parasuraman Jaisankar,Sibabrata Mukhopadhyay,Hemanta K. Majumder
Biochemical Pharmacology.2013;86(12)1673
[DOI]
82Vitamins (A&D) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs
Venkateswara Reddy Gogulamudi,Mohan Lal Dubey,Deepak Kaul,Donfack Jean Hubert,Ramesh Kandimalla,Rakesh Sehgal
Scientific Reports.2019;9(1)1673
[DOI]
83Concerted motion of structure and active site charge is required for tyrosine aminotransferase activity in Leishmania parasite
Santanu Sasidharan,Prakash Saudagar
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2020;232(1)118133
[DOI]
84Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1
B. Mukherjee,R. Mukhopadhyay,B. Bannerjee,S. Chowdhury,S. Mukherjee,K. Naskar,U. S. Allam,D. Chakravortty,S. Sundar,J.-C. Dujardin,S. Roy
Proceedings of the National Academy of Sciences.2013;110(7)E575
[DOI]
85m -Nitrocinnamic Acid Containing Lipophilic Peptide Exhibits Selective Growth Inhibition Activity against Leishmania major
Mintu Debnath,Mazharul Abbasi,Supriya Sasmal,Rupak Datta,Debasish Haldar
ChemistrySelect.2019;4(1)116
[DOI]
86Encapsulation of proteins from Leishmania panamensis into PLGA particles by a single emulsion-solvent evaporation method
Juan David Ospina-Villa,Catalina Gómez-Hoyos,Robin Zuluaga-Gallego,Omar Triana-Chávez
Journal of Microbiological Methods.2019;162(1)1
[DOI]
87Co-infection of visceral leishmaniasis and HIV-1: a surviving case in China and review of treatment strategies
Shihui Song,Xi’en Gui,Liren Guan
Emerging Microbes & Infections.2014;3(1)1
[DOI]
88Anti-parasitic Peptides from Arthropods and their Application in Drug Therapy
Ariane F. Lacerda,Patrícia B. Pelegrini,Daiane M. de Oliveira,Érico A. R. Vasconcelos,Maria F. Grossi-de-Sá
Frontiers in Microbiology.2016;7(1)1
[DOI]
89Survival Strategies of Leishmania Parasite: Too Many Questions and Few Answers
Awanish Kumar
Current Pharmacology Reports.2020;6(2)25
[DOI]
90Effect of BMAP-28 Antimicrobial Peptides on Leishmania major Promastigote and Amastigote Growth: Role of Leishmanolysin in Parasite Survival
Miriam A. Lynn,Jason Kindrachuk,Alexandra K. Marr,Håvard Jenssen,Nelly Panté,Melissa R. Elliott,Scott Napper,Robert E. Hancock,W. Robert McMaster,Paul Andrew Bates
PLoS Neglected Tropical Diseases.2011;5(5)e1141
[DOI]
91A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden
Bruno Mendes Roatt,Rodrigo Dian de Oliveira Aguiar-Soares,Levi Eduardo Soares Reis,Jamille Mirelle de Oliveira Cardoso,Fernando Augusto Siqueira Mathias,Rory Cristiane Fortes de Brito,Sydnei Magno da Silva,Nelder De Figueiredo Gontijo,Sidney de Almeida Ferreira,Jesus G. Valenzuela,Rodrigo Corrêa-Oliveira,Rodolfo Cordeiro Giunchetti,Alexandre Barbosa Reis
Frontiers in Immunology.2017;8(5)e1141
[DOI]
92Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation
Rajan Kumar Pandey,Bajarang Vasant Kumbhar,Shubham Srivastava,Ruchi Malik,Shyam Sundar,Ambarish Kunwar,Vijay Kumar Prajapati
Journal of Biomolecular Structure and Dynamics.2017;35(1)141
[DOI]
93Investigation of the antimicrobial activity of a short cationic peptide against promastigote and amastigote forms of Leishmania major (MHRO/IR/75/ER): An in vitro study
Sara khalili,Elahe Ebrahimzade,Mehdi Mohebali,Parviz Shayan,Samira Mohammadi-Yeganeh,Mehrdad Moosazadeh Moghaddam,Samira Elikaee,Behnaz Akhoundi,Mohammad Kazem Sharifi-Yazdi
Experimental Parasitology.2019;196(1)48
[DOI]
94Meglumine [email protected] nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect
Emrah Sefik Abamor,Adil M. Allahverdiyev,Melahat Bagirova,Miriam Rafailovich
Acta Tropica.2017;169(1)30
[DOI]
95Cholesterol-lowering drug, in combination with chromium chloride, induces early apoptotic signals in intracellular L. donovani amastigotes, leading to death
Amit Kumar Verma,Bhakti Laha,Monika Pandey,Uttariya Pal,Monidipa Ghosh
Journal of Biosciences.2017;42(3)427
[DOI]
96Thiolated PVP–Amphotericin B Complexes: An Innovative Approach toward Highly Mucoadhesive Gels for Mucosal Leishmaniasis Treatment
Aamir Jalil,Mulazim Hussain Asim,Iram Shahzadi,Momin Khan,Barbara Matuszczak,Andreas Bernkop-Schnürch
Biomacromolecules.2020;21(9)3658
[DOI]
97Molecular Docking and in Vitro Antileishmanial Evaluation of Chromene-2-thione Analogues
Rajiv Kumar Verma,Vijay Kumar Prajapati,Girijesh Kumar Verma,Deblina Chakraborty,Shyam Sundar,Madhukar Rai,Vikash Kumar Dubey,Maya Shankar Singh
ACS Medicinal Chemistry Letters.2012;3(3)243
[DOI]
98In Vitro and In Vivo Efficacy of Ether Lipid Edelfosine against Leishmania spp. and SbV-Resistant Parasites
Rubén E. Varela-M,Janny A. Villa-Pulgarin,Edward Yepes,Ingrid Müller,Manuel Modolell,Diana L. Muñoz,Sara M. Robledo,Carlos E. Muskus,Julio López-Abán,Antonio Muro,Iván D. Vélez,Faustino Mollinedo,Jayne Raper
PLoS Neglected Tropical Diseases.2012;6(4)e1612
[DOI]
99Defining the targets of antiparasitic compounds
Tina S. Skinner-Adams,Subathdrage D.M. Sumanadasa,Gillian M. Fisher,Rohan A. Davis,Denise L. Doolan,Katherine T. Andrews
Drug Discovery Today.2016;21(5)725
[DOI]
100L-Asparaginase of Leishmania donovani: Metabolic target and its role in Amphotericin B resistance
Jasdeep Singh,Mohd Imran Khan,Shiv Pratap Singh Yadav,Ankit Srivastava,Kislay K. Sinha,Kislay K. Ashish,Pradeep Das,Bishwajit Kundu
International Journal for Parasitology: Drugs and Drug Resistance.2017;7(3)337
[DOI]
101Roles of d-Amino Acids on the Bioactivity of Host Defense Peptides
Hao Li,Nuttapat Anuwongcharoen,Aijaz Malik,Virapong Prachayasittikul,Jarl Wikberg,Chanin Nantasenamat
International Journal of Molecular Sciences.2016;17(7)1023
[DOI]
102Roles of d-Amino Acids on the Bioactivity of Host Defense Peptides
Sujit K. Bhattacharya,Ajanta Ghosal,Sudeshna Ganguly,Sandipan Ganguly,Sabahat Azim,Shanta Dutta
International Journal of Molecular Sciences.2018;17(7)1023
[DOI]
103Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis
A. Fortin,S. Hendrickx,V. Yardley,P. Cos,H. Jansen,L. Maes
Journal of Antimicrobial Chemotherapy.2012;67(11)2707
[DOI]
104Curative efficacy of purified serine protease inhibitor PTF3 from potato tuber in experimental visceral leishmaniasis
Dibyendu Paik,Pijush Kanti Pramanik,Tapati Chakraborti
International Immunopharmacology.2020;85(11)106623
[DOI]
105Alternative to Chemotherapy—The Unmet Demand against Leishmaniasis
Nicky Didwania,Md. Shadab,Abdus Sabur,Nahid Ali
Frontiers in Immunology.2017;8(11)106623
[DOI]
106Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia
Ermias Diro,Tansy Edwards,Koert Ritmeijer,Helina Fikre,Charles Abongomera,Aderajew Kibret,Clélia Bardonneau,Peninah Soipei,Brian Mutinda,Raymond Omollo,Johan van Griensven,Eduard E. Zijlstra,Monique Wasunna,Fabiana Alves,Jorge Alvar,Asrat Hailu,Neal Alexander,Séverine Blesson,Peter C. Melby
PLOS Neglected Tropical Diseases.2019;13(2)e0007132
[DOI]
107Solute carrier protein family 11 member 1 (Slc11a1) activation efficiently inhibits Leishmania donovani survival in host macrophages
Nisha Singh,Mallikarjuna Rao Gedda,Neeraj Tiwari,Suya P. Singh,Surabhi Bajpai,Rakesh K. Singh
Journal of Parasitic Diseases.2017;41(3)671
[DOI]
108The effect of furazolidone on the physico-chemical properties of dimyristoylphosphatidylcholine bilayers: Relevance to anti-leishmanial therapy
Victor Hugo Giendruczak Martins,Marisa Raquel Rodrigues,Layoan Dantas Mascarenhas,Carla Roberta Lopes de Azambuja,Julian Londoño Londoño,Vânia Rodrigues de Lima
Journal of Molecular Structure.2014;1059(3)225
[DOI]
109The role of LPD-nanoparticles containing recombinant major surface glycoprotein ofLeishmania(rgp63) in protection against leishmaniasis in murine model
Hengameh Firouzmand,Mehrnosh Sahranavard,Ali Badiee,Ali Khamesipour,Seyedeh Hoda Alavizadeh,Afshin Samiei,Dina Soroush,Masoumeh Tavassoti Kheiri,Fereidoun Mahboudi,Mahmoud Reza Jaafari
Immunopharmacology and Immunotoxicology.2018;40(1)72
[DOI]
110Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations
Christian Bustamante,Rodrigo Ochoa,Claudia Asela,Carlos Muskus
Journal of Computer-Aided Molecular Design.2019;33(9)845
[DOI]
111Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani
Sudipta Hazra,Subhalakshmi Ghosh,Madhushree Das Sarma,Smriti Sharma,Mousumi Das,Prakash Saudagar,Vijay Kumar Prajapati,Vikash Kumar Dubey,Shyam Sundar,Banasri Hazra
Experimental Parasitology.2013;135(2)407
[DOI]
112A New Approach To The Treatment of Leishmaniasis: Quercetin-Loaded Polycaprolactone Nanoparticles
Emrah Sefik Abamor
Journal of the Turkish Chemical Society, Section A: Chemistry.2018;135(2)1071
[DOI]
113Vaccines to prevent leishmaniasis
Rajiv Kumar,Christian Engwerda
Clinical & Translational Immunology.2014;3(3)e13
[DOI]
114Current status on prevention and treatment of canine leishmaniasis
Rosa M. Reguera,Miguel Morán,Yolanda Pérez-Pertejo,Carlos García-Estrada,Rafael Balaña-Fouce
Veterinary Parasitology.2016;227(3)98
[DOI]
115Application of nanotechnology in treatment of leishmaniasis: A Review
Maryam Akbari,Ahmad Oryan,Gholamreza Hatam
Acta Tropica.2017;172(3)86
[DOI]
116Liposomal systems as carriers for bioactive compounds
Ana Maria Sper Simão,Maytê Bolean,Thuanny Alexandra Campos Cury,Rodrigo Guerino Stabeli,Rosangela Itri,Pietro Ciancaglini
Biophysical Reviews.2015;7(4)391
[DOI]
117Identification of novel leishmanicidal molecules by virtual and biochemical screenings targeting Leishmania eukaryotic translation initiation factor 4A
Emna Harigua-Souiai,Yosser Zina Abdelkrim,Imen Bassoumi-Jamoussi,Ons Zakraoui,Guillaume Bouvier,Khadija Essafi-Benkhadir,Josette Banroques,Nathan Desdouits,Hélène Munier-Lehmann,Mourad Barhoumi,N. Kyle Tanner,Michael Nilges,Arnaud Blondel,Ikram Guizani,Shaden Kamhawi
PLOS Neglected Tropical Diseases.2018;12(1)e0006160
[DOI]
118Zinc depletion promotes apoptosis-like death in drug-sensitive and antimony-resistance Leishmania donovani
Shalini Saini,Kavita Bharati,Chandrima Shaha,Chinmay K. Mukhopadhyay
Scientific Reports.2017;7(1)e0006160
[DOI]
119Plant derived therapeutics for the treatment of Leishmaniasis
Rupashree Sen,Mitali Chatterjee
Phytomedicine.2011;18(12)1056
[DOI]
120Evaluation on the leishmanicidal activity of 2-N,N'-dialkylamino-1,4-naphthoquinone derivatives
Morgana V. de Araújo,Cibelle Cabral David,José Clementino Neto,Luiz A.P.L. de Oliveira,Karoline Cristina Jatobá da Silva,Jefferson Miguel dos Santos,João Kayke S. da Silva,Victoria B.C. de A Brandão,Tania M.S. Silva,Celso A. Camara,Magna S. Alexandre-Moreira
Experimental Parasitology.2017;176(12)46
[DOI]
121Synthesis and biological evaluation of new quinoline derivatives as antileishmanial and antitrypanosomal agents
Santiago N. Chanquia,Facundo Larregui,Vanesa Puente,Carlos Labriola,Elisa Lombardo,Guadalupe García Liñares
Bioorganic Chemistry.2019;83(12)526
[DOI]
122Potential Antileishmanial Activity of a Triazole-Based Hybrid Peptide against Leishmania major
Krishnendu Maji,Mazharul Abbasi,Debasish Podder,Rupak Datta,Debasish Haldar
ChemistrySelect.2018;3(36)10220
[DOI]
123Leishmania infantum 5’-Methylthioadenosine Phosphorylase presents relevant structural divergence to constitute a potential drug target
Hela Abid,Emna Harigua-Souiai,Thouraya Mejri,Mourad Barhoumi,Ikram Guizani
BMC Structural Biology.2017;17(1)10220
[DOI]
124Leishmania infantum 5’-Methylthioadenosine Phosphorylase presents relevant structural divergence to constitute a potential drug target
Peter Mbugua Njogu,John Okombo,Kelly Chibale
BMC Structural Biology.2017;17(1)83
[DOI]
125Targeting Leishmania major parasite with peptides derived from a combinatorial phage display library
Rafik Ben Rhaiem,Mehdi Houimel
Acta Tropica.2016;159(1)11
[DOI]
126Oxidative Stress-Mediated Overexpression of Uracil DNA Glycosylase inLeishmania donovaniConfers Tolerance against Antileishmanial Drugs
Anshul Mishra,Mohd. Imran Khan,Pravin K. Jha,Ajay Kumar,Sushmita Das,Prolay Das,Pradeep Das,Kislay K. Sinha
Oxidative Medicine and Cellular Longevity.2018;2018(1)1
[DOI]
127Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases
Maria Dichiara,Agostino Marrazzo,Orazio Prezzavento,Simona Collina,Antonio Rescifina,Emanuele Amata
ChemMedChem.2017;12(16)1235
[DOI]
128Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases
Shyam Sundar,Jaya Chakravarty
ChemMedChem.2017;12(16)1293
[DOI]
129Vector Saliva in Vaccines for Visceral Leishmaniasis: A Brief Encounter of High Consequence?
Shaden Kamhawi,Hamide Aslan,Jesus G. Valenzuela
Frontiers in Public Health.2014;2(16)1293
[DOI]
130Evaluating drug resistance in visceral leishmaniasis: the challenges
S HENDRICKX,PJ GUERIN,G CALJON,SL CROFT,L MAES
Parasitology.2018;145(4)453
[DOI]
  Addresses 
  My Preferences 


JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008